Digene to Present at Deutsche Bank Securities 2007 Small Cap Growth Conference

GAITHERSBURG, Md., Feb. 6  /PRNewswire-FirstCall/ -- Digene Corporation (NASDAQ:DIGE) today announced that Joseph Slattery, Chief Financial Officer, will be presenting at the Deutsche Bank Securities 2007 Small Cap Growth Conference on Monday, February 12, 2007 at 3:20 p.m. (EST).  This conference will be held at The Ritz Carlton, Naples Florida.

A link to the Deutsche Bank live webcast and recording of Digene's presentation will be available on the Company's website, http://www.digene.com/.  The recording of Digene's presentation will be available beginning on the evening of February 12, 2007 until approximately May 12, 2007.

About Digene

A leader in molecular diagnostics, Digene develops, manufactures and markets proprietary DNA and RNA tests, with a focus on women's health. The company's flagship product, the Digene(R) HPV Test, is the only FDA-approved and CE-marked test for the human papillomavirus, the cause of essentially all cervical cancers. Digene's product portfolio also includes tests for the detection of other sexually transmitted infections, including chlamydia and gonorrhea. Digene tests are marketed in more than 40 countries worldwide. Headquartered in Gaithersburg, MD, Digene is traded on NASDAQ under the symbol DIGE. For more information, visit http://www.digene.com/ and http://www.thehpvtest.com/. 

DATASOURCE: Digene Corporation



CONTACT:  Albert Fleury, Investor Relations, Digene Corporation,

[phone]; Media - Pam Rasmussen, Digene, [phone] 



Web site:  http://www.digene.com/

http://www.thehpvtest.com/ 

Copyright